Becton Dickinson and Co raised its 2026 adjusted profit forecast to $12.72 per share after beating second-quarter earnings estimates on Thursday afternoon. Shares rose 5% as demand for GLP-1 injection pens and surgical equipment offset rising raw material costs. Cost pressures from higher oil and resin prices linked to the Middle East conflict are a key focus for investors tracking the medical supplier's margin sustainability.

GLP-1 Demand Drives Growth